Valuation: AtriCure, Inc.

Market Cap 3B 2.68B 2.47B 2.24B 4.2B 285B 4.26B 29.78B 11.79B 149B 11.26B 11.02B 470B P/E 2026 *
552x
P/E 2027 * 140x
Enterprise Value 2.85B 2.54B 2.35B 2.13B 3.98B 270B 4.05B 28.27B 11.19B 142B 10.69B 10.46B 447B EV / Sales 2026 *
4.7x
EV / Sales 2027 * 4.08x
Free-Float
96.24%
Yield 2026 *
-
Yield 2027 * -
1 day+2.85%
1 week+9.41%
Current month+8.10%
1 month+4.01%
3 months+62.58%
6 months+109.21%
Current year+53.58%
1 week 55.64
Extreme 55.64
61.11
1 month 51.63
Extreme 51.63
61.11
Current year 25.36
Extreme 25.36
61.7
1 year 25.36
Extreme 25.36
61.7
3 years 18.94
Extreme 18.94
61.7
5 years 18.94
Extreme 18.94
89.18
10 years 14.78
Extreme 14.78
89.18
Manager TitleAgeSince
Chief Executive Officer 55 02/11/2012
Director of Finance/CFO 48 01/07/2014
Chief Tech/Sci/R&D Officer 59 18/07/2017
Director TitleAgeSince
Director/Board Member 55 02/11/2012
Director/Board Member 64 11/03/2013
Director/Board Member 75 10/11/2016
Date Insider Type Main position Quantity % Market Cap. Importance
23/09/26 Sell

Chief Technology Officer

-4,519 0.0089%
11/09/26 Sell

Director

-5,313 0.0104%
08/09/26 Sell

Chief Technology Officer

-3,657 0.0072%
Change 5-day change 1-year change 3-year change Capi.($)
+2.85%+9.41%+66.59%+79.27% 3B
+0.55%+0.40%-17.85%+11.17% 179B
-0.85%+2.25%-20.61%+17.82% 118B
-1.11%+1.75%+0.28%+34.14% 117B
-3.42%+15.09%-44.71%+5.61% 93.26B
+0.23%-2.42%-1.27%+75.91% 63.16B
+0.04%+1.79%+13.52%+75.53% 55.68B
-1.79%+2.38%+4.40%-23.17% 54.18B
+1.44%+2.13%-12.32%+42.83% 44.15B
+0.03%+6.23%-4.20%-7.53% 33.95B
Average -0.19%+3.48%-1.62%+31.16% 76.14B
Weighted average by Cap. -0.60%+3.06%-12.27%+23.94%

Financials

2026 *2027 *
Net sales 606M 541M 500M 453M 848M 57.55B 862M 6.02B 2.38B 30.15B 2.28B 2.23B 95.07B 680M 607M 561M 509M 951M 64.57B 967M 6.75B 2.67B 33.83B 2.55B 2.5B 107B
Net income 7.13M 6.37M 5.88M 5.33M 9.98M 677M 10.14M 70.8M 28.03M 355M 26.77M 26.2M 1.12B 20.89M 18.65M 17.23M 15.61M 29.21M 1.98B 29.7M 207M 82.09M 1.04B 78.38M 76.72M 3.28B
Net Debt -152M -136M -125M -114M -212M -14.42B -216M -1.51B -597M -7.55B -570M -558M -23.82B -227M -202M -187M -169M -317M -21.51B -322M -2.25B -890M -11.27B -850M -832M -35.53B
Projected Income Statement - Annual - AtriCure, Inc.
Logo AtriCure, Inc.
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.
Employees
1,350
Date Price Change Volume
26/10/26 $60.76 +3.03% 226,643
23/10/26 $58.97 -0.56% 497,155
22/10/26 $59.30 +2.83% 498,177
21/10/26 $57.67 0.00% 566,328
20/10/26 $57.67 +3.85% 446,379
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - AtriCure, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
58.97USD
Average target price
57.56USD
Spread / Average Target
-2.40%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - AtriCure, Inc.
  1. Stock Market
  2. Stocks
  3. ATRC Stock